Sickle Cell Cure & Therapies

As one of the premier sickle cell centers in the country, UI Health is proud to provide a number of innovative treatments and therapies for sickle cell disease — including a cure through stem cell transplantation.

Curing Sickle Cell Disease

UI Health was the first institution outside the National Institutes of Health to cure adult patients of sickle cell disease using stem cell transplantation.

In the procedure, cells from a healthy donor — often a sibling — are transfused into the patient. Stem cells from the donor produce healthy new blood cells in the patient, eliminating symptoms of sickle cell disease.

Human leukocyte antigen (HLA) typing is used to match patients and donors for stem cell transplants. HLA markers are proteins on the surface of cells that help to regulate the immune system; the human body uses these proteins to identify which cells belong in the body and which do not. HLA markers are inherited from parents, so family members are the most likely to have matching proteins.

UI Health has transplant treatment protocols that utilize both fully matched and half-matched donors, which significantly increases the number of potential donors for each patient.

“We are curing adults with sickle cell disease, and we see that their quality of life improves vastly within just one month of the transplant,” said Dr. Damiano Rondelli, chief of the Division of Hematology/Oncology and director of the Blood & Marrow Transplant Program at UI Health.

Our Legacy of Curing Sickle Cell Disease

For more than 15 years, UI Health has provided a cure for sickle cell disease through stem cell transplantation. To date, UI Health has cured more than 60 patients of sickle cell disease from both fully matched sibling donors and half-matched relative donors.

Iesha Thomas

Iesha Thomas

Brothers Julius and Desmond

Brothers Julius (center photo, right) and Desmond (left)

Kamia Quinones with her physician Dr. Santosh Saraf

Kamia Quinones, pictured with her physician Dr. Santosh Saraf

Iesha Thomas, left, received a stem cell transplantation in 2011 and was the first adult patient at UI Health to be cured of sickle cell disease. Brothers Julius (center photo, right) and Desmond (left) were cured of sickle cell disease at UI Health through a stem cell transplant in 2013; their older brother, Clifford (center), was the donor. Kamia Quinones, pictured with her physician Dr. Santosh Saraf, was cured of sickle cell disease in 2013.


Innovative Sickle Cell Therapies Personalized for You

It is our mission at UI Health to improve the quality of life for individuals with sickle cell disease by reducing acute and chronic complications, helping patients live longer, healthier lives.

As part of the only public academic health center in Chicago, the Comprehensive Sickle Cell Center at UI Health has the expertise and resources to help you find the treatment, care plan, and support that works best for you.

We are proud to provide a number of innovative treatments and therapies for sickle cell disease, including:

  • Medication Therapy: Daily oral or routine intravenous therapies are designed to reduce the frequency of painful crises, prevent acute chest syndrome, and lower the overall risk of infections.
  • Gene Therapy: An innovative treatment that modifies a patient’s own stem cells to produce healthy hemoglobin, reducing complications from sickle cell disease.
  • Transfusion Programs: Regular infusions of healthy donor red blood cells that increase the oxygen-carrying capacity of the blood, dilute damaged sickled cells, and significantly lower the risk of stroke.
  • Stem Cell Transplant & Advanced Therapies: Stem cell transplantation, bone marrow transplantation, and newly developed gene therapies are able to permanently correct hemoglobin production and act as a functional cure for sickle cell disease.

Learn more about the transplantation process.